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Although soluble oligomeric and protoﬁbrillar assemblies
of Ab-amyloid peptide cause synaptotoxicity and poten-
tially contribute to Alzheimer’s disease (AD), the role of
mature Ab-ﬁbrils in the amyloid plaques remains contro-
versial. A widely held view in the ﬁeld suggests that the
ﬁbrillization reaction proceeds ‘forward’ in a near-irrever-
sible manner from the monomeric Ab peptide through
toxic protoﬁbrillar intermediates, which subsequently ma-
ture into biologically inert amyloid ﬁbrils that are found
in plaques. Here, we show that natural lipids destabilize
and rapidly resolubilize mature Ab amyloid ﬁbers.
Interestingly, the equilibrium is not reversed toward
monomeric Ab but rather toward soluble amyloid proto-
ﬁbrils. We characterized these ‘backward’ Ab protoﬁbrils
generated from mature Ab ﬁbers and compared them with
previously identiﬁed ‘forward’ Ab protoﬁbrils obtained
from the aggregation of fresh Ab monomers. We ﬁnd that
backward protoﬁbrils are biochemically and biophysically
very similar to forward protoﬁbrils: they consist of a wide
range of molecular masses, are toxic to primary neurons
and cause memory impairment and tau phosphorylation
in mouse. In addition, they diffuse rapidly through the
brain into areas relevant to AD. Our ﬁndings imply that
amyloid plaques are potentially major sources of soluble
toxic Ab-aggregates that could readily be activated by
exposure to biological lipids.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized by neuroﬁbrillary tangles and amyloid plaques
consisting of aggregated Ab-peptide (Hardy, 2002). Fifteen
years ago, the ‘amyloid hypothesis’ for AD has been proposed
(Selkoe, 1991; Hardy and Higgins, 1992), but the discrepan-
cies between amyloid plaque load in the brain and cognitive
impairment in the patient (Price and Morris, 1999) or mice
(Games et al, 1995) have caused a lot of controversy in the
ﬁeld (Terry, 2001). This has led to the concept of ‘protoﬁbrils’
(Harper et al, 1997; Walsh et al, 1997, 1999; Hartley et al,
1999), ‘annular assemblies’ (Lashuel et al, 2002; Bitan et al,
2003); ‘Ab-derived diffusible ligands’ (Lambert et al, 1998) or
‘soluble toxic oligomers’ (Podlisny et al, 1995, 1998; McLean
et al, 1999; Walsh et al, 2002a; Glabe and Kayed, 2006).
These species are intermediary forms between free soluble
Ab-peptides and insoluble amyloid ﬁbers and are toxic in
vitro and in vivo, whereas mature Ab-amyloid ﬁbers are
largely inert (Aksenov et al, 1996). The molecular nature of
these smaller assemblies of Ab remains rather elusive (Hepler
et al, 2006), as different sources, isolation procedures and
biophysical techniques lead to different conclusions. A num-
ber of species have been observed: dimeric and trimeric Ab-
oligomers (Podlisny et al, 1995, 1998; McLean et al, 1999;
Walsh et al, 2002a), 56*kDa oligomer assemblies from
transgenic mouse brains (Lesne et al, 2006) or larger struc-
tures that consist of 50 and more Ab peptides (Lambert et al,
1998; Walsh et al, 1999; Nilsberth et al, 2001; Chong et al,
2003; Barghorn et al, 2005; Wogulis et al, 2005; Hepler et al,
2006; Haass and Selkoe, 2007).
A b-Amyloid ﬁbrils, on the other hand, are found in the
amyloid plaques as large insoluble macromolecular assem-
blies characterized by a ‘cross-b’ ﬁber-like architecture.
Mature ﬁbrils are resistant to proteolytic cleavage, are
unaffected by denaturant concentrations that unfold globular
proteins and possess high thermostability (Booth et al, 1997;
O’Nuallain et al, 2005). Amyloid ﬁbrils from different
proteins are biologically inert, although cytotoxicity appears
primarily caused by soluble preﬁbrillar oligomers (Bucciantini
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224et al, 2002). Taken together, these observations suggest an
archetypal model for amyloid-associated pathologies in which
disease is caused by transient toxic aggregates that eventually
convert to inert amyloid deposits. These deposits would then
be simple remnants of the aggregation process playing no
signiﬁcant role in the disease process (Lomas et al, 1992). On
the other hand, amyloid ﬁbrils are not strictly irreversible but
rather in a slow dynamic equilibrium with soluble peptide
(Carulla et al, 2005; O’Nuallain et al, 2005). For instance,
amyloid ﬁbrils from the PI3 kinase-SH3 domain recycle about
half of their molecules over a period of weeks (Carulla et al,
2005). Inspired by the fact that disturbed lipid metabolism is
increasingly considered as an important factor in AD patho-
genesis, we have investigated the inﬂuence of biological
lipids on the stability of amyloid ﬁbrils of the Alzheimer’s
b-peptide 1–42 (Ab42) in relation to neurodegeneration. We
focused on sphingolipids (SM) and gangliosides (GM), which
are associated with amyloid deposits (Kakio et al, 2002;
Devanathan et al, 2006). In addition, lipid raft domains
containing cholesterol (CH), SM and GM promote Ab aggre-
gation and oligomer formation (Kakio et al, 2002; Yip et al,
2002; Zou et al, 2003; Gellermann et al, 2005; Kim et al,
2006). Peroxidized lipids and their derivatives such as
4-hydroxynonenal are involved in amyloid aggregation link-
ing oxidative stress to Ab deposition (IrmingerFinger et al,
1999). Finally, phospholipids stabilize toxic oligomers
generated from monomeric Ab (Johansson et al, 2007).
Results
Lipids convert inert amyloid ﬁbrils to a highly toxic
species
We measured the effect of lipids on mature amyloid ﬁbrils of
Ab42, in terms of their toxicity to primary neurons in vitro.
We incubated Ab42 for 2 weeks at 251C, at 1mgml
 1 in
50mM Tris-HCl, pH 7.4, and 5mM EDTA and controlled the
presence of Ab42 ﬁbrils by electron microscopy. These
mature Ab42 ﬁbrils were subsequently harvested by centri-
fugation and added to primary hippocampal mouse neurons
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Figure 1 Lipid-derived Ab protoﬁbrils cause neurotoxicity and
cell death in primary hippocampal neurons. Inert Ab ﬁbrils
(250mgml
 1,5 0 mM) were incubated with DOPC liposomes
(2.5mgml
 1) overnight while shaking and subsequently added in
a 1:10 dilution (5mM and 0.25mgml
 1 ﬁnal concentrations of ﬁbrils
and lipids, respectively) to primary cultures of hippocampal neu-
rons cultured for 18 DIV (days in vitro). (A) Neutral red incorpora-
tion by neurons after treatment with lipids (0.25mgml
 1 ﬁnal
concentration), Ab ﬁbrils (5mM ﬁnal concentration) or lipid/Ab
ﬁbrils during 48h was assayed. DOPC liposomes alone (black), Ab
ﬁbrils alone (green), Ab ﬁbril/DOPC (red), Abﬁbril/DOPC soluble
fraction obtained by extensive centrifugation (blue) or resuspended
Abﬁbril/DOPC insoluble pelleted fraction (yellow) are shown.
Values are % of control7s.e.m., Po0.002, of three independent
experiments performed in triplicate. (B) Neutral red incorporation
by neurons treated for 24h with various lipid mixtures (black) or
with soluble fraction from Ab ﬁbril/lipid mixtures (white) is shown
(concentrations as above). DOPC, dioleyl phosphatidylcholine;
DMPG, dioleyl phosphatidylglycerol, GM1, ganglioside; SM,
sphingomyelin (SM); BTE, brain total extract. Values are % of
control7s.e.m., Po0.006, of three independent experiments
performed in triplicate. Ab ﬁbrils (5mM ﬁnal concentration) or
lipid mixtures (0.25mgml
 1 ﬁnal concentration) alone had no
effect on neutral red incorporation. (C) AnnexinV/propidium iodide
(PI) staining of primary neurons. Fluorescence microscopy images
of Annexin V (green) and PI (red) staining of hippocampal neurons
cultured for 18 DIV treated with GM1, SM and BTE liposomes and
the soluble fraction of the same Ab ﬁbrils/lipid mixtures in the
concentrations mentioned above are shown. Incubation with 5mM
of Ab ﬁbrils alone did not affect this staining (not shown). (D)
Cleaved caspase-3 staining. Fluorescence microscopy images of
cleaved caspase-3 staining of hippocampal neurons cultured for
18 DIV treated with SM, GM1 and BTE liposomes and soluble
fractions of Ab ﬁbrils/lipid mixtures as mentioned above are
shown. Incubation with 5mMo fA b ﬁbrils alone did not affect this
staining (not shown). Results reveal apoptotic cell death induced by
soluble fractions of Ab ﬁbrils/lipid mixtures but not by Ab ﬁbrils or
lipids alone.
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 1 (5mM). As expected,
these mature ﬁbers were largely inert, displaying only modest
neurotoxicity as assayed by Neutral Red incorporation.
However, an overnight incubation at room temperature of
250mgml
 1 mature Ab42 ﬁbrils with a 2.5mgml
 1 liposome
suspension composed of synthetic lipid dioleyl phosphatidyl-
choline (DOPC) yielded a toxic emulsion when added to
primary hippocampal neurons at a ﬁnal concentration of
5mMA b peptide ﬁbril and 0.25mgml
 1 lipid (Figure 1A).
Importantly, neither lipid preparations (0.25mgml
 1) nor
mature amyloid ﬁbrils (5mM) alone were toxic (Figure 1A).
The toxic Ab42 ﬁbril/lipid emulsion became partitioned into
two phases that were separated by centrifugation for 20min
at 14000g. The supernatant fraction exhibited a high degree
of toxicity, whereas the pellet was largely inert (Figure 1A).
Similar lipid-induced neurotoxicity of mature Ab42 amyloid
ﬁbrils was also observed with various other synthetic and
membrane lipids, including the gangliosides GM1, sphingo-
myelin (SM) and brain total lipid extract (BTE) from cow
(Table I). Neurotoxicity of the supernatants from these pre-
parations was evaluated in primary cultures of neurons by
neutral red incorporation (Figure 1B). The supernatants
induced apoptosis, as shown by Annexin V/propidium
iodide staining (Figure 1C) and cleaved caspase-3 staining
(Figure 1D). Collectively these data strongly suggest that
biological relevant lipids, including lipid extracts from
brain, can induce the reversal of mature amyloid ﬁbril to a
soluble toxic species.
Lipids cause mature amyloid ﬁbrils to disassemble into
a protoﬁbrillar species
To determine the mechanism by which lipids cause the
conversion of inert amyloid ﬁbrils into a toxic state, we
proceeded to the biophysical characterization of ﬁbril–lipid
mixtures. As is clear from the introduction, the atypical
behavior of Ab42 in a number of biophysical techniques
has led to conﬂicting interpretations about the nature of the
toxic species (Hepler et al, 2006). For this reason, we combine
a range of biophysical assays, to obtain a maximum of
information on the nature of the toxic species we here
obtained. Transmission electron microscopy revealed that
amyloid ﬁbrils (Figure 2A) were converted by lipids to an
insoluble fraction containing fractured and highly inter-
twined amyloid material surrounded by short amyloid frag-
ments (Figure 2B), whereas the supernatant contained
protoﬁbrillar structures (Figure 2C), conﬁrming ﬁbril desta-
blization and resolubilization in the presence of lipids.
Confocal microscopy using immunostaining with the anti-
body A11 that is speciﬁc for ‘soluble preﬁbrillar oligomers’
(Kayed et al, 2003) shows not only a granular decoration of
material on the plasma membrane of primary neurons, but
also signiﬁcant internalization (Figure 2D) matching the
behavior of preﬁbrillar toxic material extracted from AD
brains (Chromy et al, 2003). Amyloid–lipid emulsions were
further deposited under a sucrose gradient and centrifuged at
100000g for 1h. We used the Ab-speciﬁc mAb 6E10 and the
oligomer-speciﬁc pAB A11 to detect Ab species. Although
both the top of the gradient and the pellet reacted with 6E10,
only the top of the gradient reacted with A11 (Figure 2E),
demonstrating that ﬁbrils are indeed resolubilized and that
the soluble fraction migrates in the same fraction as the
liposomes, whereas insoluble amyloid material was pelleted.
Dynamic light scattering (DLS) at a detection angle of 901
relative to the incident beam detected hydrodynamic radii
between 10 and 100mm in samples of mature ﬁbrils (Figure
3A1). When lipids were added to the sample (Figure 3A2),
the hydrodynamic radius dropped to a range between 100nm
and 1mm, indicating signiﬁcant heterogeneity. A sample of
lipids alone was monodispersed with an apparent radius of
roughly 200nm (Figure 3A3). A similar size distribution is
observed from light scattering measured at 1731 (back scat-
tering), excluding misinterpretations due to the angular de-
pendence of light scattering (data not shown). Both the size
distribution and heterogeneity observed by light scattering
are in excellent agreement with sizes observed by electron
microscopy, where ﬂexible protoﬁbrils are observed to curl
into spheroid shapes with dimensions between 100 and
300nm (Figure 2C). Further conﬁrmation that the amyloid
ﬁbrils revert to a protoﬁbrillar state (Walsh et al, 1997;
Hartley et al, 1999) was obtained from spectroscopic analysis,
which showed intermolecular b or cross-b structure similar to
that of mature amyloid ﬁbrils (Figure 3B and C). Circular
dichroism (CD) revealed an increase in the amplitude around
220nm, but no signiﬁcant shape change compared to the
amyloid far UV spectrum, indicating an increase in soluble
material in the amyloid–lipid mixtures with a similar b-sheet
content as the amyloid ﬁbrils (Figure 3B). Fourier-transform
infrared (FTIR) spectra indicated that lipid-induced protoﬁ-
brils possess a similar intermolecular b-extended structure
as mature ﬁbrils (corresponding to the spectral band at
1623cm
 1), but the difference FTIR spectrum revealed
some degree of unfolding in the protoﬁbrils as compared to
the mature amyloid ﬁbrils, as was apparent from the
1647cm
 1 band (Figure 3C). We proceeded to analyze our
lipid-induced protoﬁbrils by size exclusion chromatography
(SEC). When the supernatant of a lipid/ﬁbril mixture was
injected on an S75/HR10 column, a single peak at 15.8ml
was eluted (Figure 3D, green line), which immunostained
with both the 6E10 and A11 antibodies (Figure 3D). Size
determination from the elution volume yields an apparent
molecular weight of approximately 9kDa (dimeric Ab). This
estimation, however, is only valid for globular proteins that
do not interact with the column matrix. These requirements
are certainly not met here, as the analysis of the elution peak
Table I Comparison of the toxicity of SEC fractions of Ab42 mixed
with various lipids
Lipid Fraction Neutral red A11 binding
DMPG 16.9 53.076.2 ++
Cholesterol 16.9 50.573.5 +++
SM 16.9 43.172.4 +++
GM1 16.9 36.172.9 +++
BTE 16.9 25.274.3 +++
Inert Ab ﬁbrils (250mgml
 1,5 0 mM) were incubated with lipo-
somes enriched in different lipids (left column in the table)
(2.5mgml
 1) overnight while shaking and then centrifuged as
indicated previously. The SEC fractionation of the soluble part of
Ab42 ﬁbril/lipid mixtures shows a peak at 16.9ml. Toxicity of the
16.9ml peak from the various Ab42 ﬁbril/lipid emulsions is quan-
tiﬁed by neutral red incorporation into hippocampal neuronal cells.
A qualitative indication of binding to the oligomer-speciﬁc A11
antibody to the 16.9ml peak from the various Ab42 ﬁbril/lipid
emulsions detected by dot blot is also given.
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protoﬁbrillar oligomers with a size of 100–200nm. To char-
acterize the size distribution of the lipid/ﬁbril mixture, we
instead utilized an 18-angles static light scattering (SLS)
detector inline with the SEC column, which allows to infer
size information directly from the angular dependence of the
scattered light intensity in an absolute manner that is inde-
pendent from shape or gel matrix interactions. SLS indicates a
strong nonlinear angle dependence in the light scattering
intensity (Figure 3E), consistent with objects larger than
100nm, and calculated molecular weights of 80–500kDa
(between 20 and 90 monomeric units). The fact that a
heterogeneous sample elutes as a focused peak is consistent
with strong interactions with the gel matrix, as under these
conditions the elution proﬁle is no longer determined by the
size but by the strength of the column interactions and no
size separation is achieved. Taken together, the methods used
here are in agreement with earlier analysis of the structure
(Walsh et al, 1999; Hepler et al, 2006) and toxicity (Walsh
et al, 1997, 2002b) of protoﬁbrils and indicate that the sample
cannot be deﬁned by a single molecular mass.
‘Backward’ protoﬁbrils obtained by destabilizing
mature ﬁbrils using lipids are identical to ‘forward’
protoﬁbrils obtained in ageing solutions of
monomeric Ab
We proceeded to compare ﬁbril-derived protoﬁbrils (further
termed ‘backward’ protoﬁbrils) with the extensively studied
soluble protoﬁbrils formed during the aggregation process
of fresh Ab (and further termed ‘forward’ protoﬁbrils).
When we incubated monomeric Ab42 at 1mgml
 1 in
50mM Tris-HCl, pH 7.4, and 1mM EDTA at 251C, we
found, consistent with previous observations (Walsh et al,
1999; Bitan and Teplow, 2004; Klyubin et al, 2005), that
neurotoxicity of forward protoﬁbrils peaked between 24 and
48h (Figure 1F), at which point the sample contains a
mixture of protoﬁbrils and some mature ﬁbrils (Figure 4A).
Subsequently, the sample becomes inert and highly enriched
of mature amyloid ﬁbrils (Figure 2A shows 2-week-old
samples) and does not contain detectable amounts of
soluble protoﬁbrils anymore. Interestingly, toxicity of forward
protoﬁbrils and lipid-induced backward protoﬁbrils is very
similar (Figure 4B). Soluble fractions of forward protoﬁbrils
Sucrose
gradient
Sample
Buffer
6E10 A11
Figure 2 Lipids induce disassembly of mature Ab42 amyloid ﬁbrils into soluble protoﬁbrils. (A) Electron microscopy images showing mature
Ab42 amyloid ﬁbrils alone. (B)A b42 amyloid ﬁbrils were mixed with DOPC liposomes and the pellet was harvested using centrifugation; the
electron micrograph reveal strongly intertwined lipids and amyloid ﬁbrils as well as fragmented amyloid material. (C) Electron micrograph of
the soluble fraction of the previous image, which contains small oligomeric fragments. The black bar on images A, B and C indicates a size of
200nm. (D) Protoﬁbrils detection by oligomer-speciﬁc A11 antibody. Soluble fractions from Ab ﬁbrils/BTE mixtures display decorating
punctuate-like hippocampal neurons staining detected by the oligomer-speciﬁc A11 antibody (red) versus actin staining (green) revealing
binding of oligomers to the cell surface and intracellular localization at later time points. (E) ‘Floating assay’ by ultracentrifugation reveals
Alzheimer’s Ab42 oligomers in association with liposomes in amyloid/lipid mixtures (250mgml
 1 peptide, 2.5mgml
 1 lipid). After
centrifugation for 1h at 150000g, liposomes are in the top fraction, whereas protein aggregates are expected in the pellet. As 6E10
immunostaining indicates, some Ab42 material is indeed removed to the pellet, but a signiﬁcant amount is transported to the top fraction in
association with the lipids. This fraction is equally recognized by the oligomer-speciﬁc antibody A11, consistent with ﬁbril disassembly,
whereas the pellet fraction is not recognized by A11 and most likely contains intact ﬁbrils.
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Figure 3 Biophysical characterization of lipid-induced protoﬁbrils. (A) DLS spectra of mature Ab42 ﬁbrils (A1), ﬁbril/lipid mixtures (A2) and
pure liposome preparations (A3, DOPC). Apparent hydrodynamic radii are indicated on the x axis (logarithmic scale), the y axis shows the
evolution of the signal during the experiment (20s) and the color code indicates a relative intensity scale between 0 and 1. The liposome
spectrum (A3, 2.5mgml
 1 lipid concentration) reveals strong monodispersity in the sample with an average hydrodynamic radius just above
100nm, whereas the amyloid ﬁbril sample (A1, 50mM peptide concentration) contains a wider range of molecular sizes, ranging from 5 to
100 mm approximately. The spectrum of the amyloid–lipid mixture (A2, 50mM peptide concentration and 2.5mgml
 1 lipid concentration)
shows a complete loss of signal for hydrodynamic radii above 5mm. The majority of the signal shows strong heterogeneity with sizes ranging
from 100nm and 1mm, consistent with the disassembly of amyloid ﬁbrils into smaller species. (B) Far UV CD spectroscopy gives information
on the secondary structure of material in solution. The spectra of Ab42 amyloid ﬁbrils in isolation (50mM) and in the presence of liposomes
(2.5mgml
 1) containing DMPG display a marked increase in the intensity of the spectrum around 220nm, while the overall shape of the
spectrum is constant. This is consistent with an increase in the amount of soluble material rich in b-sheet content. Similar results were obtained
with other lipids (not shown). (C) FTIR yields information on the secondary structure of both the soluble and insoluble material in the sample.
The spectra of mature Ab42 ﬁbrils (50mM) and ﬁbril/lipid mixtures (BTE, 2.5mgml
 1) show a strong cross-b signal at 1623cm
 1, consistent
with a comparable b-sheet content for amyloid ﬁbrils and protoﬁbrils. However, the difference spectrum reveals an additional band at 1647,
corresponding to the formation of random coil in the amyloid/lipid mixture, consistent with partial ﬁbril disassembly. (D) SEC on a
GEHealthcare S75/HR10 column of ‘forward’ (blue line) and lipid-induced (‘backward’) oligomers (green line). For each sample, 200mlo fa n
amyloid–lipid mixture containing 250mgo fA b42 peptide and 2.5mgml
 1 lipid were injected. Notice peak elutions at 15.8ml and 16.9ml,
respectively. Upon 0.1% SDS treatment, backward oligomers elute at the same position as forward oligomers, whereas lipids elute in the void
volume (black line). For comparison, an elution trace for monomeric Ab42 is also shown (red line, elution peak at 21ml). Elution proﬁles of
amyloid ﬁbril samples show no noticeable peaks. Inset show immunostaining of the lipid fraction and the Ab42/lipid-induced oligomer fraction
of the black proﬁle using the antibody A11, which speciﬁcally detects oligomers, and the 6E10mAb, which is speciﬁc for Ab.( E) Eighteen-
angles SLS, placed inline with the SEC system, allows to determine molecular mass in an absolute manner that does not depend on interactions
with column matrix (as is the case in SEC) or assumed molecular shape (as is the case in DLS). The 15.8ml peak shown in Figure 3D was
analyzed in this manner. The Zimm plot (see Materials and methods) in Figure 3E shows the clear nonlinear dependence of the light scattering
intensity with scattering angle, consistent with a radius of gyration larger than 80nm. The red curve indicates a ﬁt to a quadratic equation (R-
squared value 40.9). The molecular masses obtained in this manner vary throughout the peak, in agreement with the heterogeneity observed
in DLS and electron microscopy and consistent with a total loss of size-sorting effects from the column due to nonspeciﬁc matrix interactions.
Masses obtained vary from 80 to 500kDa throughout the peak.
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column (Figure 3D, blue line) and appear as typical
protoﬁbrils of 100–200nm diameter by transmission electron
microscopy (Figure 4A). This slight difference in elution
volume between the forward protoﬁbrils and backward,
lipid-induced protoﬁbrils (15.8ml) is consistent with an
increase in molecular weight due to lipid association.
In agreement, upon addition of 0.1% SDS (submicellar
concentration) to amyloid–lipid mixtures before injection
on the column, a lipid peak eluted in the void volume,
whereas the lipid-induced protoﬁbrils now elute at the
same elution volume as forward protoﬁbrils (16.9ml;
Figure 3D). These data suggest that, under the incubation
condition used here, lipid-induced backward protoﬁbrils have
very similar morphological and biochemical properties as the
protoﬁbrils formed during the aggregation process of fresh
monomers.
In vivo toxicity of backward protoﬁbrils in the brain of
adult mice
To further characterize the physiological relevance of the
lipid-induced ‘backward’ oligomers, we proceeded to bilat-
eral intraventricular injection (3ml) of mature Ab42 amyloid
ﬁbrils, lipids and supernatants from amyloid–lipid mixtures
into the brain of adult mice. Immunostaining of brain
samples with the 6E10 antibody demonstrated the effective
delivery of Ab in the ventricles when both ﬁbrils and back-
ward oligomers were injected into the animals (Figure 5A).
However, within 90min of injection, we also observed Ab42
immunoreactivity away from the needle tracks into the cortex
(Figure 5A), with oligomeric preparations but not with Ab
ﬁbrils. With the latter, staining remained mostly associated
with the ventricular walls (Figure 5A). When we analyzed
brain areas further away from the needle track, we observed
very little immunostaining after Ab ﬁbril injections, whereas
backward oligomers caused signiﬁcant staining of the hippo-
campal areas (Figure 5B), indicating rapid diffusion of (some
of) these species into the brain parenchym (Figure 5B).
Interestingly, the single injection with backward oligomers
caused also mild neurotoxicity restricted to the area of the
frontal cortex (but not hippocampus) that was exposed to the
highest concentrations of toxic oligomers as revealed by
immunostaining for cleaved caspase 3 (Figure 5C) and phos-
phorylated tau (Figure 5D). Lipid or mature ﬁbrils injection
alone did not cause toxicity in the frontal cortex (Figure 5C
and D).
Backward and forward protoﬁbrils cause similar
memory defects in mouse
To further assess if the lipid-induced ‘backward’ protoﬁbrils
might cause functional deﬁcits relevant to AD, we evaluated
the acute biological effects of the injected backward oligo-
mers in exploratory and memory/learning tests. Open-ﬁeld
recording revealed increased path length covered, higher
velocity and increased frequencies of center visits, but de-
clined time spent in the center by animals injected with
backward oligomers, in sharp contrast to animals injected
with lipid samples or mature ﬁbrils alone. As all animals were
treated identically, the backward oligomers appear to speci-
ﬁcally affect brain functions that cause hyperlocomotion and
hyperactivation (Figure 6A). In a light–dark step through task
(passive avoidance test), animals were allowed to memorize
the electrical shock that follows entrance to a dark compart-
ment. When the test was repeated 24h later, animals injected
with lipids or mature ﬁbrils correctly recalled the electro-
shock and avoided to enter the dark room. Injection of
backward oligomers before the shock event prevented ani-
mals from successful memory formation, as was evidenced
by uninhibited entering of the dark compartment 24h after
electroshock (Figure 6B). In addition, contextual and audi-
tory-cue fear conditioning showed that injection of backward
oligomers 90min before conditioning severely disturbed
typical freezing behavior 24h later when the animals were
exposed again to the same contextual or auditory stimulus, in
contrast to the control mice injected with lipids or mature
amyloid alone (Figure 6C). One week after oligomer injec-
tion, mice appeared to have recovered completely and could
no longer be distinguished in open-ﬁeld activity from control
or untreated animals (not shown in ﬁgure). Thus, a single
injection of lipid-induced backward oligomers appears not to
have caused persistent functional defects, which is in excel-
lent agreement with earlier studies of ‘forward’ oligomers,
which were reported to have immediate but transient effects
on synaptic function (Wang and Hecht, 2002; Chromy et al,
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Figure 4 Morphology and toxicity of forward protoﬁbrils. (A) Electron micrograph of 48h aged solution of freshly dissolved Ab42 reveals a
mixture of protoﬁbrillar intermediates and the ﬁrst appearance of some amyloid ﬁbrils. (B) Neutral red incorporation by hippocampal neurons
treated with monomers (5mM), mature Ab ﬁbrils (5mM), forward oligomers generated from monomers during 48h aggregation (5mM) and
soluble fractions of Ab ﬁbrils/lipid mixtures at 5mM and 0.25mgml
 1 ﬁnal concentrations of ﬁbrils and lipids, respectively (termed as
‘backward lipid-derived protoﬁbrils’, see text). Values are % of control7s.e.m., Po0.008, of two independent experiments performed in
quadruplicates.
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behavioral effects of forward and backwards protoﬁbrils, we
performed identical behavioral tests on animals injected with
forward oligomers generated from Ab42 monomers that were
incubated for 48h at room temperature at a concentration of
1mgml
 1. These animals showed very similar behavioral
defects: open-ﬁeld recording indicated hyperlocomotion and
hyperactivation effects (result not shown) and light–dark step
through tests (passive avoidance) showed that animals in-
jected with forward oligomers failed to memorize the elec-
trical shock, in contrast to control individuals injected with
buffer (Figure 6D). In addition, contextual and auditory-cue
fear conditioning showed that injection of forward oligomers
90min before conditioning severely disturbed freezing beha-
vior 24h later, in contrast to the control mice (Figure 6E).
Our results conﬁrm the behavioral effects of forward
protoﬁbrils generated from Ab monomers (Hartley et al,
1999; Walsh et al, 2002a; Kamenetz et al, 2003; Cleary
et al, 2005; Klyubin et al, 2005; Lesne et al, 2006;
Townsend et al, 2006) and show that lipid-induced protoﬁ-
brils generated from mature Ab ﬁbrils have very similar
pathophysiological effects.
Discussion
We demonstrate in the current work that amyloid ﬁbrils,
usually considered as highly stable and biologically inert
structures, can be destabilized and easily reverted to soluble
and highly toxic Ab aggregates by biological lipids that are
present in the brain. This suggests that part of the critical
Figure 5 Lipid-derived Ab protoﬁbrils diffuse rapidly in the brain of mice. (A) Detection of intraventricularly injected Ab preparations in the
mouse brain. Inert Ab ﬁbrils (250mgml
 1,5 0 mM) were incubated with BTE liposomes (2.5mgml
 1) overnight while shaking and then
centrifuged as indicated above. A volume of 3mlo fA b ﬁbrils/BTE mixtures soluble fractions from these preparations were injected bilaterally
into the lateral ventricles. The same volume of mature ﬁbrils (50mM) or lipid preparations (2.5mgml
 1) alone were injected into two control
groups. After 1.5h, mice were killed, and staining with the Ab-speciﬁc mAb 6E10 antibody revealed strongly pronounced Ab staining along the
needle track and in the ventricles in ﬁbrils/BTE mixtures soluble fractions-injected brains (A, middle panel). Similar staining in the ventricles is
observed when Ab ﬁbrils alone are injected, but much less staining is observed along the needle tracks (A, right panel), indicating partial
perfusion of soluble Ab species, but not mature ﬁbrils in the brain tissue. Brains of mice injected with BTE lipid alone did not show Ab-speciﬁc
staining (A, left panel). (B) Distribution of intraventricularly injected Ab preparations in the hippocampus of mouse brain. After 1.5h of
injection, strong and speciﬁc staining of the hippocampal area is observed with mAb 6E10 when ﬁbrils/BTE mixture-soluble fractions are
injected (B, middle panel). Such staining is not observed with lipids (B, left panel) or Ab ﬁbrils injected alone (A, right panel). (C) Cleaved
Caspase-3 detection in mouse brain injected with Ab preparations. Injection of ﬁbrils/BTE mixture-soluble fraction for 24h caused cleaved
caspase-3 (cell signaling) activation in frontal cortex area (C, middle panel). Some caspase-3 staining limited to the area around ventricles and
needle track is seen with ﬁbril injections (A, right panel). Such staining is not observed with lipids (B, left panel). (D) Phosphorylated tau
detection in mouse brain injected with Ab preparations. Phosphorylated tau staining (AT8mAb) was detected in the same frontal cortex areas
as for cleaved caspase-3 in brains injected with ﬁbrils/BTE mixture-soluble fraction and ﬁbrils. Data indicate that apoptotic markers such as
caspase-3 activation and tau phosphorylation are associated with distribution of soluble Ab in brains injected with ﬁbrils/BTE mixture-soluble
fraction, but less in ﬁbrils-injected brains.
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the relative amounts of lipids in the direct environment of the
plaques. Remarkably, the toxic species we identify shares
many properties with previously characterized ‘forward’
oligomeric aggregates in terms of biophysical, cell biological
and behavioral assays. Although in SEC and other biophysi-
cal assays the impression could arise that these structures are
homogenous, further extensive biophysical characterization
indicates that the size distribution of these oligomeric aggre-
gates is rather heterogeneous in nature, ranging from 80 to
500kDa, although their morphology is protoﬁbrillar. The
appearance of these species indeed varies somewhat with
the assay used, likely reﬂecting their dynamic nature. In that
regard, our ﬁndings are very similar to the overall picture
emerging from the literature and synthesized recently by
Hepler et al (2006) that also the classical forward oligomeric
Ab structures have to be considered as a spectrum of dynamic
structures that are likely in fast equilibrium with each other.
Lipids are apparently promoting the equilibrium toward the
protoﬁbrillar pools, inducing toxicity of the amyloid mixture.
Interestingly our data also conﬁrm that these oligomeric
structures diffuse very rapidly throughout the brain and
preferentially localize to speciﬁc regions of the brain, such
as the hippocampus.
Our ﬁndings have important implications for the under-
standing and the treatment of amyloidoses and, in particular,
AD. They suggest the possibility that inert amyloid plaques or
ﬁbrils could be turned into highly toxic oligomers when local
physicochemical parameters are altered due, for instance, to a
change in lipid metabolism. Our results could explain why
the amount of amyloid deposits and the severity of associated
disease symptoms in AD do not necessarily correlate.
Individual and temporal differences in brain lipid content
could indeed explain why some patients with large amounts
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Figure 6 Lipid-derived and forward Ab protoﬁbrils cause learning and memory impairments in mice. A volume of 3mlo fA b ﬁbrils/BTE
mixtures soluble fractions, mature ﬁbrils or lipids were injected bilaterally into the lateral ventricles under local anesthesia as indicated in
Figure 5. After 1.5h, mice were evaluated in several behavioral assays. (A) Open-ﬁeld recording of mice injected with backward protoﬁbrils.
The table displays total path length covered, velocity, frequencies of center visits and time spent in center. Data reveal that injection of Ab
ﬁbrils/BTE mixture-soluble fractions caused increased velocity and path length covered and increased frequency of visits to the center, but
declined time spent in the center. Overall, these indicate hyperactivation and hyperactivity. This effect is not observed in groups injected with
mature ﬁbrils and lipids alone (values are mean7s.e.m., Po0.007, n¼20, 21 and 13 for BTE, Ab ﬁbrils and Ab ﬁbrils/BTE, respectively). (B)
Passive avoidance test of mice injected with backward protoﬁbrils. Light–dark step through test showed latency of entrance during the training
accompanied with electrical shock (white) and during the testing 24h later (black). Injection of Ab ﬁbrils/BTE mixture-soluble fractions 1.5h
before the shock impaired memory in contrast to groups injected with mature ﬁbrils and lipids alone (values are latency mean7s.e.m.,
Po0.04, n¼15 for each experimental group). (C) Contextual fear response test of mice injected with backward protoﬁbrils. Mice groups
injected with BTE (white), Ab ﬁbrils (gray) and Ab ﬁbrils/BTE mixture-soluble fractions (black) were provided with an electrical stimulus
accompanied by an auditory conditioned stimulus 1.5h after the injection. Memorization of this combination is tested after 24h by the freezing
behavior of the mice exposed to the similar context or to the auditory conditioning stimulus. Data show decreased freezing events (indicating
memory disturbances) during exposure to context and to conditioned stimulus in the group injected with Ab ﬁbrils/BTE mixture-soluble
fractions in contrast to groups injected with mature ﬁbrils and lipids alone (values are % freezing mean7s.e.m., Po0.005, n¼20, 21 and 13 for
BTE, Ab ﬁbrils and Ab ﬁbrils/BTE, respectively). (D) Passive avoidance test of mice injected with forward protoﬁbrils. Light–dark step through
test showing latency of entrance during the training accompanied with electrical shock (weight) and during the testing 24h later (black)
(values are latency mean7s.e.m., Po0.001, n¼10 for oligomers group and 6 for control group). (E) Contextual fear response test of mice
injected with forward protoﬁbrils. Freezing response during the test blocks in groups injected with vehicle (weight) and forward Ab oligomers
(black) 1.5h after the injection (values are % freezing mean7s.e.m., Po0.005, n¼12 for oligomers group and 6 for control group).
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although others are severely affected. In any event, our data
strongly suggest that amyloid plaques, although apparently
biologically inert, should not be considered as inert remnants
of the aggregation process, as the amyloid ﬁbrils they contain
can, under certain conditions, be rapidly reverted to toxic
species. In that sense, the amyloid plaques should rather be
considered as reservoirs of toxicity.
Materials and methods
Chemicals
Alzheimer’s b-peptide 1–42 was purchased from Sigma-Aldrich. All
puriﬁed and synthetic lipids were obtained from Avanti Lipids
(USA). Uranyl acetate was obtained from BDH.
Preparation of lipid vesicles and liposomes
All lipids were obtained from Avanti Polar Lipids (USA) except the
ganglioside GM1, which was obtained from Larodan Chemicals
(Sweden). The stock concentration was 20mgml
 1 in chloroform.
The various lipid mixtures discussed in the paper were prepared in
Corex round-bottomed glass tubes, dried under a gentle N2 stream
and resuspended in 400ml of diethylether for 10min at room
temperature, after which they were quickly dried in a waterbath at
501C. The resulting ﬁlm was placed under vacuum for 1h to remove
trace solvent and rehydrated in 800ml of 50mM Tris, pH 7.5, 1mM
EDTA and 0.1mM NaCl. The resulting vesicle suspension was
allowed to stabilize for 1h at room temperature, sonicated for 15s
(Branson soniﬁer) and extruded 11 times with an Avanti mini-
extruder (Avanti Polar Lipids, USA). This suspension was puriﬁed
on an S75 gel ﬁltration column using an Akta system from
GEHealthcare (UK). The approximate lipid concentration in the
stock preparation was 10mgml
 1. To obtain stable liposomes, it is
not possible to use pure preparations of certain lipids such as
cholesterol or GM1. Therefore, we used a more complex composi-
tion as follows: (i) pure DOPC; (ii) 50% DOPC, 50% DMPG; (iii)
35% DOPC, 35% DMPG, 30% cholesterol; (iv) 30% DOPC, 30%
DMPG, 30% cholesterol, 10% GM1; (v) 30% DOPC, 30% DMPG,
30% cholesterol, 10% SM; (vi) 30% DOPC, 30% DMPG, 30%
cholesterol, 10% brain total extract.
Preparation of amyloid ﬁbrils, amyloid/lipid mixtures and
Ab oligomers
Amyloid ﬁbrils of the Alzheimer’s b-peptide 1–42 were obtained by
incubation of 200mM peptide solution in 50mM Tris, pH 7.5, for 2
weeks at room temperature. Amyloid ﬁbril/lipid mixtures were
prepared by diluting ﬁbril and liposome stock solutions 1
4 in
liposomes buffer and incubating for 1–16h at room temperature,
shaking at 700r.p.m. Oligomers were generated from monomers by
incubation of 200mM peptide solution in 50mM Tris, pH 7.5, for
48h and subsequent extensive centrifugation, and the supernatant
as the oligomer-enriched preparation was used immediately. The
presence of oligomers in the supernatant was validated by probing
with anti-oligomer-speciﬁc antibody (A11).
Additional methods can be found in Supplementary data.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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